Catalyst

Slingshot members are tracking this event:

FDA Announces Black Box Requirement for Risk of HBV Reactivation for at Least 9 Brand Name Drugs in Hepatitis C Treatment

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
GILD

100%
ABBV

100%
MRK

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 05, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Black Box Requirement, Hbv Reactivation, 9 Brand Name Drugs, Hepatitis C Treatment, Sovaldi, Harvoni, Viekira Pak, Zepatier